Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata causes hair loss, has no cure, and various treatments exist.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Rhodococcus equi causes severe pneumonia in young foals, and effective vaccines are needed due to foals' weak immune responses.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

Scientists turned mouse stem cells into skin cells that can grow into skin layers and structures.

Nerves and chemicals in the body can affect hair growth and loss.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Using human fat tissue derived stem cells in micrografts can safely and effectively increase hair density in people with hair loss.

Vitiligo is linked to autoimmune diseases and hearing issues, so hearing tests are recommended for patients.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

The study found that Keratosis Pilaris Atrophicans is a genetic skin condition that starts in childhood, involves inflammation and scarring, and current treatments are only somewhat effective.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

The conclusion is that recognizing hair growth cycles can improve the precision of dietary and health assessments from hair analysis.

Careful planning and patient counseling can lead to excellent hair transplant results, often in one or two sessions.

Human hair follicles produce and respond to erythropoietin, helping protect against stress.